Epsilon Healthcare ( ) - 株価, ニュースと分析ASX:EPN

このページの翻訳は実験的なもので、現在開発中です。お待ちしております！

EPN 株式概要

Epsilon Healthcare Limited operates as a healthcare and pharmaceuticals company primarily in Australia and Canada.

EPN ファンダメンタル分析
スノーフレーク・スコア
評価	2/6
将来の成長	0/6
過去の実績	0/6
財務の健全性	2/6
配当金	0/6

報酬

リスク分析

過去5年間で収益は年間4.2%減少しました。

キャッシュランウェイが1年未満である

意味のある時価総額がありません ( A$7M )

株式の流動性は非常に低い

+1 さらなるリスク

Epsilon Healthcare Limited 競合他社

Cann Global

ASX:CGB

AU$5.4m

Island Pharmaceuticals

ASX:ILA

AU$9.1m

Firebrick Pharma

ASX:FRE

AU$11.1m

Nyrada

ASX:NYR

AU$10.4m

価格と性能

の歴代最高値、変動、値下がりまとめEpsilon Healthcare
過去の株価
現在の株価	AU$0.024
52週高値	AU$0.034
52週安値	AU$0.016
ベータ	0.92
11ヶ月の変化	0%
3ヶ月変化	0%
1年変化	20.00%
33年間の変化	-89.57%
5年間の変化	-95.60%
IPOからの変化	-94.07%

Does Epsilon Healthcare (ASX:EPN) Have A Healthy Balance Sheet?

Oct 13

Recent updates

株主還元

	EPN	AU Pharmaceuticals	AU 市場
7D	0%	-1.8%	0.5%
1Y	20.0%	67.1%	9.9%

業界別リターン: EPN過去 1 年間で53.6 % の収益を上げたAustralian Pharmaceuticals業界を下回りました。

リターン対市場: EPN過去 1 年間で8.2 % の収益を上げたAustralian市場を上回りました。

価格変動

Is EPN's price volatile compared to industry and market?
EPN volatility
EPN Average Weekly Movement	n/a
Pharmaceuticals Industry Average Movement	9.6%
Market Average Movement	8.3%
10% most volatile stocks in AU Market	15.9%
10% least volatile stocks in AU Market	3.2%

安定した株価: EPN過去 3 か月間に大きな価格変動はありませんでした。

時間の経過による変動: 過去 1 年間のEPNのボラティリティの変化を判断するにはデータが不十分です。

会社概要

設立	従業員	CEO（最高経営責任者	ウェブサイト
2016	n/a	Daniel Sanghera	epsilonhealthcare.com.au

Epsilon Healthcare Limited 基礎のまとめ

Epsilon Healthcare の収益と売上を時価総額と比較するとどうか。
EPN 基礎統計学
時価総額	AU$7.21m
収益（TTM）	-AU$5.93m
売上高(TTM)	AU$7.21m

1.0x

P/Sレシオ

-1.2x

PER（株価収益率

EPN は割高か？

公正価値と評価分析を参照

収益と収入

最新の決算報告書（TTM）に基づく主な収益性統計
EPN 損益計算書（TTM）
収益	AU$7.21m
売上原価	AU$5.09m
売上総利益	AU$2.12m
その他の費用	AU$8.05m
収益	-AU$5.93m

直近の収益報告

Jun 30, 2023

次回決算日

該当なし

一株当たり利益（EPS）	-0.02
グロス・マージン	29.46%
純利益率	-82.17%
有利子負債／自己資本比率	27.1%

EPN の長期的なパフォーマンスは？

過去の実績と比較を見る

EPN 株式概要

報酬

リスク分析

Epsilon Healthcare Limited 競合他社

ASX:CGB

AU$5.4m

ASX:ILA

AU$9.1m

ASX:FRE

AU$11.1m

ASX:NYR

AU$10.4m

価格と性能

最新ニュース

Epsilon Healthcare Receive Notice from Watercrest Asset Management Pty Ltd

Epsilon Healthcare Receive Notice from Watercrest Asset Management Pty Ltd

Epsilon Healthcare Limited Announces Board Appointments

Epsilon Healthcare Limited Announces Terminates Peter Giannopoulos as Chief Executive Officer

Does Epsilon Healthcare (ASX:EPN) Have A Healthy Balance Sheet?

Non-Executive Deputy Chairman recently bought AU$67k worth of stock

Recent updates

Epsilon Healthcare Receive Notice from Watercrest Asset Management Pty Ltd

Epsilon Healthcare Receive Notice from Watercrest Asset Management Pty Ltd

Epsilon Healthcare Limited Announces Board Appointments

Epsilon Healthcare Limited Announces Terminates Peter Giannopoulos as Chief Executive Officer

Does Epsilon Healthcare (ASX:EPN) Have A Healthy Balance Sheet?

Non-Executive Deputy Chairman recently bought AU$67k worth of stock

First half 2023 earnings released: AU$0.002 loss per share (vs AU$0.035 loss in 1H 2022)

Non-Executive Deputy Chairman recently bought AU$55k worth of stock

Is Epsilon Healthcare (ASX:EPN) Using Too Much Debt?

New minor risk - Share price stability

Epsilon Healthcare Appoints Peter Giannopoulos as Chief Executive Officer, Effective 23 May, 2023

Full year 2022 earnings released: AU$0.066 loss per share (vs AU$0.048 loss in FY 2021)

Epsilon Healthcare Limited Announces Executive Changes

Epsilon Healthcare Limited Appoints Mark Audet as Chief Financial Officer

No independent directors

Epsilon Healthcare Limited Announces Resignation of Simon Rowe as Director

Epsilon Healthcare Limited Announces Board Changes

Epsilon Healthcare Limited Announces Resignation of Nicholas Marshall as Chief Financial Officer

Epsilon Healthcare Limited Announces Executive Changes

First half 2022 earnings released: AU$0.035 loss per share (vs AU$0.022 loss in 1H 2021)

Epsilon Healthcare Limited Announces Resignation of Dr. Rob Jenny as A Director

Epsilon Healthcare Limited Announces Resignation of Jarrod White as Chief Executive Officer

Epsilon Healthcare Limited Appoints Patrick Baiyu Xu as Director

Epsilon Healthcare Limited, Annual General Meeting, May 31, 2022

Epsilon Healthcare Limited announced that it expects to receive AUD 2.1 million in funding

No independent directors

Full year 2021 earnings released: AU$0.046 loss per share (vs AU$0.066 loss in FY 2020)

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Epsilon Healthcare Limited announced that it expects to receive AUD 2.898 million in funding from CPS Capital

First half 2021 earnings released: AU$0.022 loss per share (vs AU$0.039 loss in 1H 2020)

We Think Epsilon Healthcare (ASX:EPN) Has A Fair Chunk Of Debt

Epsilon Healthcare Limited (ASX:EPN) entered into binding heads of agreement to acquire AlternaMed Pty Ltd. from Cannvalate PTY LTD for AUD 4.3 million.

First half 2021 earnings released: AU$0.022 loss per share (vs AU$0.039 loss in 1H 2020)

Joint Company Secretary Philip Leighfield has left the company

Is Epsilon Healthcare (ASX:EPN) Weighed On By Its Debt Load?

Tetra Health Partners with Astrid Healthcare to Operates the Astrid Dispensary in South Yarra

Non Executive Director has left the company

Epsilon Healthcare Limited Announces Resignation of Gary Radcliff as Non-Executive Director

Is Epsilon Healthcare (ASX:EPN) Using Too Much Debt?

Full year 2020 earnings released: AU$0.069 loss per share (vs AU$0.088 loss in FY 2019)

THC Global Group Limited announced that it expects to receive AUD 2.75 million in funding

New 90-day high: AU$0.29

THC Global Group Limited Announces CEO Changes

First half earnings released

New 90-day low - AU$0.24

New 90-day low - AU$0.26

THC Global Group Limited (ASX:THC) completed the acqusition of Tetra Pty Ltd from Meta Growth Corp. (TSXV:META) and others.

New 90-day low - AU$0.27

THC Global Group Limited has completed a Follow-on Equity Offering in the amount of AUD 1.535 million.

株主還元

価格変動

会社概要

Epsilon Healthcare Limited 基礎のまとめ

1.0x

-1.2x

収益と収入